Leibniz-Forschungsinstitut fur Molekulare Pharmakologie (FMP)

The FMP conducts basic research in Molecular Pharmacology with the aim to identify novel bioactive molecules and to characterize their interactions with their biological targets in cells or organisms. These compounds are useful tools in basic biomedical research and may be further developed for the treatment, prevention, or diagnosis of disease. To this aim FMP researchers study key biological processes and corresponding diseases, such as cancer, aging including osteoporosis, or neurodegeneration. They also develop and apply advanced technologies ranging from screening technologies over NMR based methods to proteomics and in vivo models

Chemische biologie,strukturbiologie,physiologie,zellbiologie,massenspektrometrie,chemie,pharmakologie,mikroskopie,screening unit,nmr,and kryo-em

Leibniz-forschungsinstitut fur molekulare pharmakologie (fmp) operates in the Research services industry.

Leibniz-forschungsinstitut fur molekulare pharmakologie (fmp)'s revenue is 11m - 100m

Leibniz-forschungsinstitut fur molekulare pharmakologie (fmp) has 51 - 200 employees.